5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MR FLAIR volumetric biomarkers of disease progression and survival in patients with glioma
    Meeting Abstract

    Tringale, K. R.; Moreno, R.; Mellinghoff, I.; Thomas, T. M.; Bahtia, A.; Bale, T. A.; Young, R. J.; Beal, K.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Elucidating the biologic basis of ER(+)/Her2(-) breast cancer tumors containing extensive tumor infiltrating lymphocytes through morphologic and genomic profiling
    Meeting Abstract

    Johnson, C. B.; Chandran, S. S.; Wen, H. Y.; Razavi, P.; Schietinger, A.; Klebanoff, C. A.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Mutation detection in cell-free DNA using ultra-high depth sequencing in prospectively collected newly diagnosed endometrial cancer patients
    Meeting Abstract

    Ashley, C. W.; Brown, D.; Lakhman, Y.; Nincevic, J.; Stylianou, A.; Wu, M.; Selenica, P.; Patel, J. A.; Berger, M. F.; Leitao, M. M. Jr; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • The anti-HER3 monoclonal antibody seribantumab effectively inhibits growth of patient-derived and isogenic cell line and xenograft models with NRG1 rearrangements
    Meeting Abstract

    Odintsov, I.; Gladstone, E.; Sisso, W. J.; Delasos, L.; Lui, A. J. W.; Sisso, E. M.; Vojnic, M.; Khodos, I.; Mattar, M. S.; de Stanchina, E.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • CHD1-loss promotes tumor heterogeneity and therapy resistance in prostate cancer
    Meeting Abstract

    Zhang, Z.; Zhou, C.; Li, X.; Sawyers, C.; Mu, P.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Identification of the cells of origin and tumor heterogeneity in neuroendocrine prostate cancer (NEPC) by single-cell analysis
    Meeting Abstract

    Zhao, J. L.; Zaidi, S.; Chan, J.; Wadosky, K.; Karthaus, W.; Choi, D.; Agudelo Rivera, A.; Gopalan, A.; Rathkopf, D.; Carver, B.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Mathematical modeling of tumor heterogeneity to optimize treatment scheduling and delay the evolution of resistance
    Meeting Abstract

    Mathur, D.; Taylor, B. P.; Chatila, W.; Schultz, N.; Razavi, P.; Xavier, J.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • MYC influences metastatic heterogeneity in pancreatic cancer
    Meeting Abstract

    Maddipati, R.; Norgard, R. J.; Baslan, T.; Rathi, K. S.; Zhang, A.; Raman, P.; Wengyn, M. D.; Yamazoe, T.; Li, J.; Balli, D.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Community partnerships expand access to tumor molecular profiling
    Meeting Abstract

    Reynolds, T.; Jack, K.; Kemeny, M.; Bulone, L.; Gonsky, J.; Kampel, L. J.; Hyman, D.; Solit, D. B.; Conklin, C.; McMillan, S.; more...
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save
  • Polyethnic-1000: Advancing cancer genomics by studying ethnically diverse, underserved patient populations in New York
    Meeting Abstract

    Hubert, B.; Froeling, F.; Arora, K.; Chu, T.; Robine, N.; Zody, M.; Oschwald, D.; Varmus, H.; Sawyers, C.; Tuveson, D.
    Cancer Epidemiology Biomarkers and Prevention (2020)

    Fulltext@MSK | Save